Clinical Trials Browser

Phase 1 × INDUSTRY × Advanced/Metastatic Solid Tumors × Clear all

NCT07480681 2026-03-18

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT07141706 2026-03-09

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT04501276 2026-01-08

A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

Phase 1 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05614258 2026-01-08

Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05718895 2025-06-05

CLINCH

Phase 1 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05394168 2024-04-01

A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05277402 2024-02-26

ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT02444793 2019-02-27

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Phase 1 Terminated

24 enrolled 34 charts

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT01092052 2012-09-07

Study of NMS-1116354 in Advanced/Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT00996255 2009-10-16

Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced/Metastatic Solid Tumors